A. Mergani, A. Mansour, O. M. Saleh, R. N. Zahran, A. M. Mustafa, M. A. Mohammed, T. Askar
{"title":"GSTM1和T1零变异体对沙特阿拉伯Turabah人群2型糖尿病易感性的影响","authors":"A. Mergani, A. Mansour, O. M. Saleh, R. N. Zahran, A. M. Mustafa, M. A. Mohammed, T. Askar","doi":"10.5897/jde2017.0116","DOIUrl":null,"url":null,"abstract":"Type 2 diabetes mellitus (T2DM) is characterized by chronic hyperglycemia and associated with an increased production of reactive oxygen species (ROS) affecting beta cells in pancreas. Glutathione S-transferases (GSTs) are a family of antioxidant enzymes that include several classes of GSTs. These enzymes have important roles in decreasing ROS species and act as a kind of antioxidant defense. In a case-control study, the role of GSTMI and TI polymorphisms in predisposition for T2DM using multiplex polymerase chain reaction in 103 T2DM patients and 170 healthy controls from Turabah Province, Saudi Arabia was investigated. GSTM1 null variant was associated with higher genetic risk predisposing to T2DM in the study population. Our study revealed that individuals who are GSTM1 null genotype are associated with 1.863 times risk for predisposition to T2DM (Odds ratio = 1.863; 95% CI = 1.265 - 2.742; P-value=0.00001). While GSTT1 polymorphism has no role in genetic predisposing to T2DM in the study population ( Odds ratio = 1.053; 95% CI = 0.921 - 1.203 ) and its contribution in susceptibility for T2DM was only detected with combined double deletions with GSTM1 null variant in the population ( P-value = 0.041, Odds Ratio = 1.104; 95% CI = 0.991 - 1.230 ) . These results indicated that individuals who have GSTM1 null variant or GSTM1 and GSTT1 double deletion are at higher risk for developing T2DM than those who are positive genotyped for GSTT1 gene.","PeriodicalId":13900,"journal":{"name":"International Journal of Diabetes and Endocrinology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GSTM1 and T1 null variants effects on the predisposition to type 2 diabetes mellitus in Turabah population, Saudi Arabia\",\"authors\":\"A. Mergani, A. Mansour, O. M. Saleh, R. N. Zahran, A. M. Mustafa, M. A. Mohammed, T. Askar\",\"doi\":\"10.5897/jde2017.0116\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Type 2 diabetes mellitus (T2DM) is characterized by chronic hyperglycemia and associated with an increased production of reactive oxygen species (ROS) affecting beta cells in pancreas. Glutathione S-transferases (GSTs) are a family of antioxidant enzymes that include several classes of GSTs. These enzymes have important roles in decreasing ROS species and act as a kind of antioxidant defense. In a case-control study, the role of GSTMI and TI polymorphisms in predisposition for T2DM using multiplex polymerase chain reaction in 103 T2DM patients and 170 healthy controls from Turabah Province, Saudi Arabia was investigated. GSTM1 null variant was associated with higher genetic risk predisposing to T2DM in the study population. Our study revealed that individuals who are GSTM1 null genotype are associated with 1.863 times risk for predisposition to T2DM (Odds ratio = 1.863; 95% CI = 1.265 - 2.742; P-value=0.00001). While GSTT1 polymorphism has no role in genetic predisposing to T2DM in the study population ( Odds ratio = 1.053; 95% CI = 0.921 - 1.203 ) and its contribution in susceptibility for T2DM was only detected with combined double deletions with GSTM1 null variant in the population ( P-value = 0.041, Odds Ratio = 1.104; 95% CI = 0.991 - 1.230 ) . These results indicated that individuals who have GSTM1 null variant or GSTM1 and GSTT1 double deletion are at higher risk for developing T2DM than those who are positive genotyped for GSTT1 gene.\",\"PeriodicalId\":13900,\"journal\":{\"name\":\"International Journal of Diabetes and Endocrinology\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Diabetes and Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5897/jde2017.0116\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5897/jde2017.0116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
2型糖尿病(T2DM)的特征是慢性高血糖,并与影响胰腺β细胞的活性氧(ROS)的产生增加有关。谷胱甘肽s -转移酶(GSTs)是一个抗氧化酶家族,包括几种类型的GSTs。这些酶在减少活性氧方面具有重要作用,是一种抗氧化防御。在一项病例对照研究中,使用多重聚合酶链反应研究了来自沙特阿拉伯Turabah省的103名T2DM患者和170名健康对照者的GSTMI和TI多态性在T2DM易感性中的作用。在研究人群中,GSTM1零变异与易患T2DM的较高遗传风险相关。我们的研究显示,GSTM1零基因型个体与1.863倍的2型糖尿病易感性相关(优势比= 1.863;95% ci = 1.265 - 2.742;假定值= 0.00001)。而GSTT1多态性在研究人群中与2型糖尿病的遗传易感性无关(优势比= 1.053;95% CI = 0.921 - 1.203),其对T2DM易感性的贡献仅在人群中与GSTM1零变异合并双缺失时检测到(p值= 0.041,优势比= 1.104;95% ci = 0.991 - 1.230)。这些结果表明,GSTM1零变异或GSTM1和GSTT1双缺失的个体发生T2DM的风险高于GSTT1基因型阳性的个体。
GSTM1 and T1 null variants effects on the predisposition to type 2 diabetes mellitus in Turabah population, Saudi Arabia
Type 2 diabetes mellitus (T2DM) is characterized by chronic hyperglycemia and associated with an increased production of reactive oxygen species (ROS) affecting beta cells in pancreas. Glutathione S-transferases (GSTs) are a family of antioxidant enzymes that include several classes of GSTs. These enzymes have important roles in decreasing ROS species and act as a kind of antioxidant defense. In a case-control study, the role of GSTMI and TI polymorphisms in predisposition for T2DM using multiplex polymerase chain reaction in 103 T2DM patients and 170 healthy controls from Turabah Province, Saudi Arabia was investigated. GSTM1 null variant was associated with higher genetic risk predisposing to T2DM in the study population. Our study revealed that individuals who are GSTM1 null genotype are associated with 1.863 times risk for predisposition to T2DM (Odds ratio = 1.863; 95% CI = 1.265 - 2.742; P-value=0.00001). While GSTT1 polymorphism has no role in genetic predisposing to T2DM in the study population ( Odds ratio = 1.053; 95% CI = 0.921 - 1.203 ) and its contribution in susceptibility for T2DM was only detected with combined double deletions with GSTM1 null variant in the population ( P-value = 0.041, Odds Ratio = 1.104; 95% CI = 0.991 - 1.230 ) . These results indicated that individuals who have GSTM1 null variant or GSTM1 and GSTT1 double deletion are at higher risk for developing T2DM than those who are positive genotyped for GSTT1 gene.